BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 26244352)

  • 1. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
    Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
    Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral isotretinoin on muscle strength in patients with acne vulgaris: a prospective controlled study.
    Mülkoğlu C; Karaosmanoğlu N
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):17. PubMed ID: 33743831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
    Rademaker M
    Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced central corneal thickness in patients with isotretinoin treatment.
    Yuksel N; Ozer MD; Akcay E; Ozen U; Uzun S
    Cutan Ocul Toxicol; 2015; 34(4):318-21. PubMed ID: 25597375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study.
    Akman A; Durusoy C; Senturk M; Koc CK; Soyturk D; Alpsoy E
    Arch Dermatol Res; 2007 Dec; 299(10):467-73. PubMed ID: 17710426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
    Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
    J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of hematuria in acne vulgaris patients during isotretinoin treatment.
    Yesilkaya B; Alli N; Artuz RF; Ulu E; Kartal D; Cinar SL
    Cutan Ocul Toxicol; 2017 Mar; 36(1):74-76. PubMed ID: 26938860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical approach for the use of oral isotretinoin for infantile acne.
    Barnes CJ; Eichenfield LF; Lee J; Cunningham BB
    Pediatr Dermatol; 2005; 22(2):166-9. PubMed ID: 15804310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral isotretinoin on serum folic acid levels.
    Javanbakht AM; Pour HM; Tarrahic MJ
    J Drugs Dermatol; 2012 Sep; 11(9):e23-4. PubMed ID: 23135667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome of acne vulgaris with oral isotretinoin.
    Bener A; Lestringant GG; Ehlayel MS; Saarinen K; Takiddin AH
    J Coll Physicians Surg Pak; 2009 Jan; 19(1):49-51. PubMed ID: 19149981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.